Hypha LabsFUNI +9.59% 9-Day RSI is 43.06 as of Jun. 28, 2026. The stock has 2 warning signs investors should review. Among 218 Medical Diagnostics & Research companies, Hypha Labs ranks better than 59.63% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-06-28), Hypha Labs's 9-Day RSI is 43.06.
The industry rank for Hypha Labs's 9-Day RSI or its related term are showing as below:
FUNI's 9-Day RSI is ranked better than 59.63% of 218
companies
in the Medical Diagnostics & Research industry
Industry Median: 47.71
vs FUNI: 43.06
Hypha Labs (OTCPK:FUNI) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Hypha Labs 9-Day RSI Related Terms
FUNI vs IVRO, IDTA, NSTM: 9-Day RSI Comparison
For the Diagnostics & Research subindustry, Hypha Labs's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hypha Labs 9-Day RSI vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Hypha Labs's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Hypha Labs's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hypha Labs (FUNI) has a 9-Day RSI of 43.06 as of Jun. 28, 2026. According to the industry distribution chart, Hypha Labs ranks #88 out of 218 companies in the Medical Diagnostics & Research industry, placing it in the top 40.4%.
Is Hypha Labs' 9-Day RSI too high?
Hypha Labs' current 9-Day RSI is 43.06. The Medical Diagnostics & Research industry median 9-Day RSI is 47.71. Hypha Labs' value of 43.06 is 9.7% below this industry median. Based on the distribution chart, Hypha Labs ranks #88 out of 218 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint.
How does Hypha Labs' 9-Day RSI compare to IVRO and IDTA?
According to the Medical Diagnostics & Research industry distribution chart, Hypha Labs ranks #88 out of 218 companies for 9-Day RSI. This puts Hypha Labs in the upper half of its industry. The industry median 9-Day RSI is 47.71. Hypha Labs' value of 43.06 is 9.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Diagnostics & Research company?
The median 9-Day RSI among Medical Diagnostics & Research companies is 47.71, based on 218 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hypha Labs's current 9-Day RSI of 43.06 is 9.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median 9-Day RSI is 47.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hypha Labs's current 9-Day RSI is 43.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypha Labs stock overvalued right now?
Hypha Labs (FUNI) has a current 9-Day RSI of 43.06. The current 9-Day RSI is 43.06 and 9.7% below the Medical Diagnostics & Research industry median of 47.71. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Hypha Labs (FUNI), the current 9-Day RSI is 43.06 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hypha Labs Inc engaged in the research, development, and commercialization of the Hypha Micropearl accelerator, an in-home, web-based, computer-controlled bioreactor designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company's easy-to-use device, together with replaceable cartridges ordered through its exclusive app, safely and effectively produced enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contained active mushroom ingredients in a concentrated, easy-to-handle, tasteless, and odorless form that could be incorporated into various foods and beverages without altering flavor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FUNI has been successfully added to your